04/10/2020 10:58 AM EDT |
| Neuro-oncologist Marta Penas-Prado, M.D., shares information about clinical trials at NIH investigating the effectiveness of an immunotherapy drug to treat people with rare brain and spine tumors. She explains the goals of the trials, who can participate and how, and what patients can expect. Learn more at www.cancer.gov/clinicaltrials/ and www.cancer.gov/clinicaltrials/ |
FALLO MEDICACIÓN IMPORTADA VS. MEDICACIÓN NACIONAL
Hace 17 horas


No hay comentarios:
Publicar un comentario